Wendy F. Dicicco

Insider Reports History

Entity
Individual
Signature
/s/ Ron Honig, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Wendy F. Dicicco:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SWK Holdings Corp Director Common Stock 6.18K $111K $17.95 Dec 30, 2022 Direct
EyePoint Pharmaceuticals, Inc. Director Common Stock 9.97K $77.6K $7.79 Aug 20, 2024 Direct
Akari Therapeutics Plc Interim CFO Ordinary Shares, par value $0.0001 per share 158M May 1, 2024 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 25K Jan 5, 2024 Direct
Renovacor, Inc. Chief Financial Officer Common Stock 0 $8.00 Dec 1, 2022 Direct
Renovacor, Inc. Chief Financial Officer Stock Option 0 Dec 1, 2022 Direct

Insider Reports Filed by Wendy F. Dicicco

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EYPT EyePoint Pharmaceuticals, Inc. Aug 20, 2024 1 $20K 4 Aug 21, 2024 Director
AKTX Akari Therapeutics Plc May 1, 2024 1 $0 4 May 3, 2024 Interim CFO
EYPT EyePoint Pharmaceuticals, Inc. Jan 5, 2024 1 $0 4 Jan 9, 2024 Director
AKTX Akari Therapeutics Plc Jan 1, 2024 0 $0 3 Jan 2, 2024 Interim CFO
EYPT EyePoint Pharmaceuticals, Inc. Jun 20, 2023 2 $0 4 Jun 22, 2023 Director
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2023 2 $0 4 Feb 13, 2023 Director
SWKH SWK Holdings Corp Dec 30, 2022 2 $33.5K 4 Jan 4, 2023 Director
RCOR Renovacor, Inc. Dec 1, 2022 7 $0 4 Dec 5, 2022 Chief Financial Officer
SWKH SWK Holdings Corp Sep 30, 2022 2 $33.5K 4 Oct 4, 2022 Director
SWKH SWK Holdings Corp Jun 30, 2022 1 $19.9K 4 Jul 5, 2022 Director
RCOR Renovacor, Inc. Jun 17, 2022 1 $0 4 Jun 21, 2022 Chief Financial Officer
RCOR Renovacor, Inc. Jun 17, 2022 0 $0 3 Jun 21, 2022 Chief Financial Officer
SWKH SWK Holdings Corp Mar 31, 2022 1 $19.8K 4 Apr 4, 2022 Director
SWKH SWK Holdings Corp Feb 15, 2022 0 $0 3 Feb 22, 2022 Director
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2022 4 $0 4 Feb 11, 2022 Director
RCOR Renovacor, Inc. Jan 24, 2022 2 $0 4 Jan 26, 2022 Interim CFO
RCOR Renovacor, Inc. Sep 3, 2021 1 $0 4 Sep 8, 2021 Interim CFO
RCOR Renovacor, Inc. Sep 2, 2021 0 $0 3 Sep 7, 2021 Interim CFO
EYPT EyePoint Pharmaceuticals, Inc. Jun 22, 2021 2 $0 4 Jun 23, 2021 Director